Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-19

Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for a vaccine therapy in stage III/IV melanoma, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Erlangen | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED